Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 21.74 | N/A |
| PEG Ratio (TTM) | -0.98 | N/A |
| P/S Ratio (TTM) | 3.86 | N/A |
| P/B Ratio (TTM) | 3.80 | N/A |
| P/FCF Ratio (TTM) | 146.83 | N/A |
| Price to 5YR AVG Earnings Ratio | 0.11 | N/A |
| Price to 5YR AVG FCF Ratio | 0.58 | N/A |
Profitability (75%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 11.45% | N/A |
| ROE (TTM) | 18.58% | N/A |
| Net Profit Margin (TTM) | 17.79% | N/A |
| ROIC 5YR AVG | 25.06% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -26.45% | 9.63% | 28.60% |
| Revenue | 3.96% | 11.72% | 12.68% |
| Net Income | -3.84% | 9.62% | 28.73% |
| Cash Flow | 13.26% | 0.78% | 17.79% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.92 | N/A |
| Quick Ratio (TTM) | 1.36 | N/A |
| D/E Ratio (TTM) | 0.14 | N/A |
| Interest Coverage (TTM) | 28.39 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 2.38 | N/A |
| LTL to 5YR AVG FCF | 0.26 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.10% | N/A |